ETFs Holding SNSS »    SNSS Historical Stock Prices »
SNSS News Video: Tue, Oct 31, 2017, 10:33 AM — Tuesday 10/31 Insider Buying Report: SNSS

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Sunesis Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of new therapeutics for the treatment of cancer. Co.'s primary activities are conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. Co.'s primary program is vecabrutinib, a non-covalent inhibitor of Bruton's Tyrosine Kinase. Co. is also developing SNS-510, a phosphoinositide-dependent kinase-1 inhibitor licensed from Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited. Self directed investors in Sunesis Pharmaceuticals Inc will be interested in keeping up with all Sunesis Pharmaceuticals Inc news they can find, both SNSS news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on SNSS. At RediNews, we simplify this task by presenting both SNSS news releases originating from Sunesis Pharmaceuticals Inc itself, and SNSS news from a variety of media outlets. Visitors can browse this news online and through our SNSS RSS news feed.


SNSS News — Articles, Videos, & Press Releases

First Week of June 21st Options Trading For Sunesis Pharmaceuticals (SNSS)
Friday, May 10, 2019, 10:35 AM — Stock Options Channel
What's in the Cards for Sunesis (SNSS) This Earnings Season?
Wednesday, May 1, 2019, 7:26 AM — Zacks
5 Cancer-Fighting Stocks to Boost Portfolio Gains
Wednesday, March 27, 2019, 12:47 PM — Zacks
Will Sunesis Pharmaceuticals Continue to Surge Higher?
Friday, March 15, 2019, 6:21 AM — Zacks
Puma Biotech (PBYI) Q4 Loss Narrows, Nerlynx Pulls Stock Up
Friday, March 1, 2019, 9:17 AM — Zacks
Agios (AGIO) Q4 Earnings Beat, Tibsovo Sales Push Up Stock
Friday, February 15, 2019, 1:25 PM — Zacks
Acorda (ACOR) Q4 Earnings and Revenues Surpass Estimates
Friday, February 15, 2019, 9:29 AM — Zacks
SNSS is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:


RediNews invites you to check out our oh so simple RSS feeds. You don't have to be the webmaster of an investor relations website, integrating investor relations components through an enterprise portal, to work with RSS. Even if you've never worked with a feed for a stock quote for website pages, from a stock market content provider, you can pick up an RSS feed. RSS is not a custom stock feed for website pages, there is nothing custom about it. Rather than custom web content delivered via non-standard XML, our RSS feeds are based on the Really Simple Syndication protocol. To give our feeds a try, look for the RSS icon for any news page (which will look like this): . The feeds can be requested on a symbol by symbol basis, so ideally our news could go on a stock quote page by symbol, or on a broader market page next to a free index chart or index table of the market averages, especially our sector by sector feeds which update intraday on a live basis as new news is added to our database. So whether it is a list of recent news next to an intraday chart, an end of day summary of the markets with all of the most recent news, or a list of the market makers for a given stock, our news can fit in well with the other stock market content your website features.

SNSS News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.